Literature DB >> 26584056

Vaccine Serotypes of Streptococcus pneumoniae with High-level Antibiotic Resistance Isolated More Frequently Seven Years After the Licensure of PCV7 in Beijing.

Shuang Lyu1, Kai-Hu Yao, Fang Dong, Bao-Ping Xu, Gang Liu, Quan Wang, Wei Shi, Jing-Jing Tong, Kun-Ling Shen, Yong-Hong Yang.   

Abstract

BACKGROUND: Streptococcus pneumoniae 7-valent conjugate vaccine (PCV7) was made available in China in the private sector in September 2008.
METHODS: This study investigated the serotype distribution, antibiotic resistance, and molecular characteristics of S. pneumoniae in hospitalized pediatric patients. Pneumococcal isolates were collected from hospitalized children younger than 14 years. Their serotypes were determined using Quellung reactions with antisera; antibiotic resistance against 13 antimicrobials was tested using the E-test method or disc diffusion. The sequence types (STs) were analyzed with multilocus sequence typing.
RESULTS: A total of 187 pneumococcal specimens were collected, including 21 invasive and 166 noninvasive isolates. The prevailing serotypes were 19F (31.6%), 19A (19.8%), 23F (11.2%), 6A (9.1%), 14 (9.1%) and 15B (5.9%). The coverage rates of PCV7, PCV10 and PCV13 were 56.2% (105/187), 56.7% (106/187) and 86.1% (161/187), respectively. The overall nonsusceptibility rate against penicillin was 8.0%; however, this rate would have been 91.5% if based on an oral breakpoint. All but one of the isolates were highly resistant to erythromycin. Multidrug resistance was exhibited by 177 (94.7%) isolates. The 5 predominant multilocus sequence typings for all pneumococci were ST271 (24.1%), ST320 (18.2%), ST81 (7.5%), ST876 (7%) and ST3397 (5.3%), which were primarily related to serotypes 19F, 19A, 23F, 14 and 15B, respectively. CC271 was the most frequent antibiotic-resistant complex clone.
CONCLUSIONS: The coverage rates of PCVs were high, and the antibiotic resistance rates were of serious concern among hospitalized children. Universal immunization using PCVs would likely prevent episodes of S. pneumoniae diseases and the spread of antibiotic resistance in Beijing.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26584056     DOI: 10.1097/INF.0000000000001000

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  10 in total

1.  Health and economic impact of the pneumococcal conjugate vaccine in hindering antimicrobial resistance in China.

Authors:  Ember Yiwei Lu; Hui-Han Chen; Hongqing Zhao; Sachiko Ozawa
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-30       Impact factor: 11.205

2.  Identification and molecular epidemiology of routinely determined Streptococcus pneumoniae with negative Quellung reaction results.

Authors:  Ju Jia; Wei Shi; Fang Dong; Qingying Meng; Lin Yuan; Changhui Chen; Kaihu Yao
Journal:  J Clin Lab Anal       Date:  2022-02-16       Impact factor: 2.352

Review 3.  Macrolide Resistance in Streptococcus pneumoniae.

Authors:  Max R Schroeder; David S Stephens
Journal:  Front Cell Infect Microbiol       Date:  2016-09-21       Impact factor: 5.293

4.  Serotype prevalence and antibiotic susceptibility patterns of pneumococcal isolates in Zunyi city, China.

Authors:  Meijing Shen; Run Yao; Huan Yue; Jingzhi Zhang; Min Chen; Weiwei Zhang; Daishun Liu; Kaifeng Wu
Journal:  Saudi Med J       Date:  2017-12       Impact factor: 1.484

5.  Clinical characteristics, antimicrobial resistance, and risk factors for mortality in paediatric invasive pneumococcal disease in Beijing, 2012-2017.

Authors:  Man Jiang; Xi Wang; Liang Zhu; Yong-Hong Yang; Kai-Hu Yao; Fang Dong; Wei Shi; Qing Wang; Wen-Qi Song; Gang Liu
Journal:  BMC Infect Dis       Date:  2022-04-05       Impact factor: 3.090

6.  Serotype distribution of Streptococcus pneumoniae and potential impact of pneumococcal conjugate vaccines in China: A systematic review and meta-analysis.

Authors:  Kaile Chen; Xiyan Zhang; Wei Shan; Genming Zhao; Tao Zhang
Journal:  Hum Vaccin Immunother       Date:  2018-02-26       Impact factor: 4.526

Review 7.  Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?

Authors:  Matthew J Cheesman; Aishwarya Ilanko; Baxter Blonk; Ian E Cock
Journal:  Pharmacogn Rev       Date:  2017 Jul-Dec

8.  Antimicrobial susceptibility and fluctuations in clonal complexes of serogroup 6 Streptococcus pneumoniae isolates collected from children in Beijing, China, between 1997 and 2016.

Authors:  Wei Shi; Ying Liu; Qinghong Meng; Lin Yuan; Wei Gao; Kaihu Yao
Journal:  Braz J Microbiol       Date:  2018-03-14       Impact factor: 2.476

9.  Serotype Distribution, Antimicrobial Susceptibility, and Multilocus Sequencing Type (MLST) of Streptococcus pneumoniae From Adults of Three Hospitals in Shanghai, China.

Authors:  Xin-Xin Li; Shu-Zhen Xiao; Fei-Fei Gu; Sheng-Yuan Zhao; Qing Xie; Zi-Ke Sheng; Yu-Xing Ni; Jie-Ming Qu; Li-Zhong Han
Journal:  Front Cell Infect Microbiol       Date:  2019-11-27       Impact factor: 5.293

10.  Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae causing invasive diseases in China: a meta-analysis.

Authors:  Jinjian Fu; Rongsong Yi; Yongjiang Jiang; Shaolin Xu; Peixu Qin; Zhuoxin Liang; Jichang Chen
Journal:  BMC Pediatr       Date:  2019-11-11       Impact factor: 2.125

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.